Correlation Between Dyne Therapeutics and Kura Oncology
Can any of the company-specific risk be diversified away by investing in both Dyne Therapeutics and Kura Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyne Therapeutics and Kura Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyne Therapeutics and Kura Oncology, you can compare the effects of market volatilities on Dyne Therapeutics and Kura Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyne Therapeutics with a short position of Kura Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyne Therapeutics and Kura Oncology.
Diversification Opportunities for Dyne Therapeutics and Kura Oncology
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Dyne and Kura is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Dyne Therapeutics and Kura Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kura Oncology and Dyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyne Therapeutics are associated (or correlated) with Kura Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kura Oncology has no effect on the direction of Dyne Therapeutics i.e., Dyne Therapeutics and Kura Oncology go up and down completely randomly.
Pair Corralation between Dyne Therapeutics and Kura Oncology
Considering the 90-day investment horizon Dyne Therapeutics is expected to generate 0.58 times more return on investment than Kura Oncology. However, Dyne Therapeutics is 1.71 times less risky than Kura Oncology. It trades about -0.02 of its potential returns per unit of risk. Kura Oncology is currently generating about -0.21 per unit of risk. If you would invest 3,078 in Dyne Therapeutics on August 27, 2024 and sell it today you would lose (133.00) from holding Dyne Therapeutics or give up 4.32% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Dyne Therapeutics vs. Kura Oncology
Performance |
Timeline |
Dyne Therapeutics |
Kura Oncology |
Dyne Therapeutics and Kura Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dyne Therapeutics and Kura Oncology
The main advantage of trading using opposite Dyne Therapeutics and Kura Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyne Therapeutics position performs unexpectedly, Kura Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kura Oncology will offset losses from the drop in Kura Oncology's long position.Dyne Therapeutics vs. Stoke Therapeutics | Dyne Therapeutics vs. Pliant Therapeutics | Dyne Therapeutics vs. Cytokinetics | Dyne Therapeutics vs. Revolution Medicines |
Kura Oncology vs. Protagonist Therapeutics | Kura Oncology vs. Merus BV | Kura Oncology vs. Replimune Group | Kura Oncology vs. Kalvista Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |